| 1 |
32743826 | Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease. | 2021 Mar |
2 |
| 2 |
27126635 | Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson's disease. | 2016 Jul 1 |
1 |
| 3 |
27234572 | Delineating pathological pathways in a chemically induced mouse model of Gaucher disease. | 2016 Aug |
2 |
| 4 |
27655403 | Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice. | 2016 Dec 1 |
1 |
| 5 |
26104567 | Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease. | 2015 Sep 15 |
2 |
| 6 |
19576930 | Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. | 2009 Nov |
2 |
| 7 |
18346921 | Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels. | 2008 Jun |
1 |
| 8 |
10037475 | Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells. | 1999 Mar |
1 |
| 9 |
7769132 | Glucosylceramides stimulate murine epidermal hyperproliferation. | 1995 Jun |
1 |
| 10 |
1386724 | Inhibition of glucocerebrosidase and induction of neural abnormality by cyclophellitol in mice. | 1992 Sep |
2 |
| 11 |
33720 | Destruction and resynthesis of mouse beta-glucosidases. | 1979 Feb 1 |
1 |